Age over 18 years

Functional class of New York Heart Association (NYHA) II-III

Diagnosis of pulmonary hypertension (PH) by right heart catheterization, as follows:

Mean pulmonary arterial pressure (mPAP) \>=25 mmHg

Pulmonary vascular resistance (PVR) ≥240 din / s / cm5

Pulmonary interlock pressure (PCWP) ≤15 mmHg

Patients with optimized PAH treatment, including intensified treatment with diuretics and who have remained stable for at least 2 months before entering the study (changes in medical treatment are not expected during the entire 12-week study period)

Be able to understand and be willing to sign the informed consent form

Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension

What this study is about